Evidence map›Paper›PMID 37473731›Full record

ArticleCell systems2023

BayesTME: An end-to-end method for multiscale spatial transcriptional profiling of the tissue microenvironment.

Haoran Zhang, Miranda V Hunter, Jacqueline Chou, Jeffrey F Quinn, Mingyuan Zhou, Richard M White, Wesley Tansey

Open access · hybridAbstract read
In one paragraph

Article in Cell systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Multi-omics to study chronic respiratory diseases and viral infections.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Haoran ZhangDepartment of Computer Science, University of Texas at Austin, Austin, TX 78712, USA.
Miranda V HunterDepartment of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jacqueline ChouDepartment of Physiology, Biophysics, & Systems Biology, Weill Cornell Medical College, New York, NY 10065, USA.
Jeffrey F QuinnComputational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mingyuan ZhouMcCombs School of Business, University of Texas at Austin, Austin, TX 78712, USA.
Richard M WhiteLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
Wesley TanseyComputational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: tanseyw@mskcc.org.
Memorial Sloan Kettering Cancer Center · USThe University of Texas at Austin · USCornell University · USUniversity of Oxford · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
The Center for Tumor-Immune Systems Biology at MSKCCU54CA274492 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Christina S Leslie · 2022 to 2026
$16.3M
Dissecting the complexity of metastasis with mathematical models and quantitative experiments with in zebrafishR01CA229215 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WHITE, RICHARD MARK, XAVIER, JOAO · 2018 to 2022
$3.1M
Probabilistic Multiscale Modeling of the Tumor MicroenvironmentR37CA271186 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Wesley Tansey · 2023 to 2026
$2.7M
Evolutionary dynamics of melanoma metastasisDP2CA186572 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WHITE, RICHARD MARK · 2013 to 2013
$2.7M
Lipid programs in melanocyte transformationR01CA238317 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI OVERHOLTZER, MICHAEL H., WHITE, RICHARD MARK · 2020 to 2025
$2.0M
NCI NIH HHS DP2 CA186572NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA229215NCI NIH HHS R01 CA238317NCI NIH HHS R37 CA271186NCI NIH HHS U54 CA274492
6 · The paper itself

Abstract

Spatial variation in cellular phenotypes underlies heterogeneity in immune recognition and response to therapy in cancer and many other diseases. Spatial transcriptomics holds the potential to quantify such variation, but existing analysis methods are limited by their focus on individual tasks such as spot deconvolution. We present BayesTME, an end-to-end Bayesian method for analyzing spatial transcriptomics data. BayesTME unifies several previously distinct analysis goals under a single, holistic generative model. This unified approach enables BayesTME to deconvolve spots into cell phenotypes without any need for paired single-cell RNA-seq. BayesTME then goes beyond spot deconvolution to uncover spatial expression patterns among coordinated subsets of genes within phenotypes, which we term spatial transcriptional programs. BayesTME achieves state-of-the-art performance across myriad benchmarks. On human and zebrafish melanoma tissues, BayesTME identifies spatial transcriptional programs that capture fundamental biological phenomena such as bilateral symmetry and tumor-associated fibroblast and macrophage reprogramming. BayesTME is open source.

Indexed as

BenchmarkingZebrafishAnimalsBayes TheoremGene Expression ProfilingHumansMacrophagesBayesian methodsmachine learningspatial gene expressionspatial modelingspatial transcriptomicstumor microenvironment

Identifiers

PMID37473731
PMCPMC10368078
OpenAlexW4384830693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.